Discovery of a RIPK2 Scaffolding Inhibitor for the Treatment of Joint Autoimmune Diseases

被引：0

作者：

Wlodarska, Marta ^{[1
]}

Van Huis, Chad ^{[2
]}

Hoss, Florian ^{[3
]}

Meyer, Rosana ^{[1
]}

Lu, Xiaokang ^{[2
]}

Koelmel, Dominik ^{[2
]}

Sanchez, Brian ^{[2
]}

Lesch, Chuck ^{[2
]}

Telling, Alissa ^{[2
]}

Minns, Martin ^{[1
]}

Mbah, Nneka ^{[2
]}

Lacan, Isabelle ^{[1
]}

Aversa, Robert ^{[1
]}

Lesburg, Charles ^{[1
]}

Yu, Carmen ^{[2
]}

Soisson, Stephen ^{[1
]}

Dales, Natalie ^{[1
]}

Patrick, Darryl ^{[1
]}

Opipari, Anthony ^{[2
]}

Pan, Shifeng ^{[4
]}

Franchi, Luigi ^{[2
]}

机构：

[1] Odyssey Therapeut, Boston, MA USA

[2] Odyssey Therapeut, Ann Arbor, MI USA

[3] Odyssey Therapeut, Frankfurt, Germany

[4] Odyssey Therapeut, San Diego, CA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0061

引用

页码：102 / 103

页数：2

共 50 条

[21] Discovery of VENT-03: A Novel Clinical cGAS Inhibitor for the Treatment of SLE and Other Autoimmune Diseases
Pike, Kelly A.
Fradet, Nadine
Gaudreault, Samuel
Skeldon, Alexander M.
Beveridge, Ramsay E.
Cyr, Patrick
Sgarioto, Nicolas
Le Gros, Philippe
Seliniotakis, Eleftheria
Dumais, Valerie
Smith, Jacklyn
Stewart, James I. P.
Gharaee-Kermani, Mehrnaz
Kahlenberg, Michelle J.
Crackower, Michael A.
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3141 - 3142
[22] Joint NOD2/RIPK2 Signaling Regulates IL-17 Axis and Contributes to the Development of Experimental Arthritis
Vieira, Silvio M.
Cunha, Thiago M.
Franca, Rafael F. O.
Pinto, Larissa G.
Talbot, Jhimmy
Turato, Walter M.
Lemos, Henrique P.
Lima, Jonilson B.
Verri, Waldiceu A., Jr.
Almeida, Sergio C. L.
Ferreira, Sergio H.
Louzada-Junior, Paulo
Zamboni, Dario S.
Cunha, Fernando Q.
JOURNAL OF IMMUNOLOGY, 2012, 188 (10): : 5116 - 5122
[23] Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165
Wrobleski, Stephen T.
Moslin, Ryan
Lin, Shuqun
Zhang, Yanlei
Spergel, Steven
Kempson, James
Tokarski, John S.
Strnad, Joann
Zupa-Fernandez, Adriana
Cheng, Lihong
Shuster, David
Gillooly, Kathleen
Yang, Xiaoxia
Heimrich, Elizabeth
McIntyre, Kim W.
Chaudhry, Charu
Khan, Javed
Ruzanov, Max
Tredup, Jeffrey
Mulligan, Dawn
Xie, Dianlin
Sun, Huadong
Huang, Christine
D'Arienzo, Celia
Aranibar, Nelly
Chiney, Manoj
Chimalakonda, Anjaneya
Pitts, William J.
Lombardo, Louis
Carter, Percy H.
Burke, James R.
Weinstein, David S.
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (20) : 8973 - 8995
[24] DISCOVERY OF NOVEL OSTEOARTHRITIS SUSCEPTIBILITY GENES, COMMON PATHWAYS, AND A MOUSE MODEL USING THE HYPERINFLAMMATORY HUMAN RIPK2 DISEASE ALLELE
Grunwald, D. J.
Ma, Y.
Weis, J.
Jurynec, M. J.
OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S380 - S380
[25] Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases
Farmer, Luc J.
Ledeboer, Mark W.
Hoock, Thomas
Arnost, Michael J.
Bethiel, Randy S.
Bennani, Youssef L.
Black, James J.
Brummel, Christopher L.
Chakilam, Ananthsrinivas
Dorsch, Warren A.
Fan, Bin
Cochran, John E.
Halas, Summer
Harrington, Edmund M.
Hogan, James K.
Howe, David
Huang, Hui
Jacobs, Dylan H.
Laitinen, Leena M.
Liao, Shengkai
Mahajan, Sudipta
Marone, Valerie
Martinez-Botella, Gabriel
McCarthy, Pamela
Messersmith, David
Namchuk, Mark
Oh, Luke
Penney, Marina S.
Pierce, Albert C.
Raybuck, Scott A.
Rugg, Arthur
Salituro, Francesco G.
Saxena, Kumkum
Shannon, Dean
Shlyakter, Dina
Swenson, Lora
Tian, Shi-Kai
Town, Christopher
Wang, Jian
Wang, Tiansheng
Wannamaker, M. Woods
Winquist, Raymond J.
Zuccola, Harmon J.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (18) : 7195 - 7216
[26] Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers
Jia, Hong
Deng, Wei
Hao, Baoyu
Cai, Min
Guo, Dong
Cai, Yu
Dai, Xiaoming
Wu, Zhipeng
He, Weigang
Wang, Jian
Wang, Guanglin
Xia, Sumei
Li, Na
Su, Weiguo
Dai, Guangxiu
ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (05): : 595 - 601
[27] BI 706039 IS A POTENT AND SELECTIVE INHIBITOR OF RIPK2 AND IMPROVES INTESTINAL INFLAMMATION IN THE TRUC MOUSE MODEL OF INFLAMMATORY BOWEL DISEASE
Ermann, Joerg
Matmusaev, Mederbek
Haley, Emma
Braun, Clemens
Jost, Felix
Mayer-Wrangowski, Svenja
Ting, Naitee
Li, Frank
Terenzio, Donna
Chime, Jane
Lukas, Susan
Panzenbeck, Mark
Csordas, David
Zheng, Jie
Mierz, Diane
King, Frank J.
Klimowicz, Alexander C.
Fine, Jay S.
Miller, Craig
Fogal, Steve
Byrne, Fergus
GASTROENTEROLOGY, 2021, 160 (06) : S326 - S326
[28] The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease
Ermann, Joerg
Matmusaev, Mederbek
Haley, Emma K.
Braun, Clemens
Jost, Felix
Mayer-Wrangowski, Svenja
Hsiao, Peng
Ting, Naitee
Li, Li
Terenzio, Donna
Chime, Jane
Lukas, Susan
Patnaude, Lori
Panzenbeck, Mark
Csordas, David
Zheng, Jie
Mierz, Diane
Simpson, Tom
King, F. James
Klimowicz, Alex P.
Mbow, M. Lamine
Fine, Jay S.
Miller, Craig A.
Fogal, Steve E.
Byrne, Fergus R.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2021, 321 (05): : G500 - G512
[29] Discovery of DWP212525, a Potent JAK3 and BTK Dual Target Inhibitor for the Treatment of Autoimmune Diseases
Shin, Yong Dae
Jung, Jae-Hun
Kim, Eun Kyung
Im, Sohee
Jun, Sunah
Kim, NamYoun
Jeong, SeungHwarn
Hyun, Hyaejung
Park, Joon Seok
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[30] Discovery of DWP213388, a Potent ITK and BTK Dual Target Inhibitor with Excellent Efficacy, As a Treatment for Autoimmune Diseases
Jung, Jae Hun
Eom, Deokki
Jeon, Seong-Uk
Shin, Yong Dae
Kim, Wolyoung
Jung, Jaehyun
Li, Qingri
Hyun, Hyaejung
Park, Joon Seok
ARTHRITIS & RHEUMATOLOGY, 2018, 70

← 1 2 3 4 5 →